PT-141, also known as Bremelanotide, was initially developed as a potential
treatment for sexual dysfunction, specifically female sexual arousal disorder
and male erectile dysfunction.
PT-141 works by activating the melanocortin receptors in the brain, which play
a role in regulating sexual behavior and arousal. It has been found to increase
sexual desire and arousal in both men and women.
In clinical trials, PT-141 has been shown to be effective in treating female
sexual arousal disorder and male erectile dysfunction. It has been found to
increase sexual desire and improve sexual function in both men and women.
PT-141 is typically administered via injection, either subcutaneously or
intranasally. It is important to note that PT-141 is not a cure for sexual
dysfunction and may not work for everyone. It is also not recommended for
use in individuals with a history of cardiovascular disease or uncontrolled high
blood pressure.
PT-141 has also been found to have potential therapeutic applications beyond
sexual dysfunction. It has been shown to have neuroprotective properties and
may have potential in treating conditions such as Parkinson's disease and
multiple sclerosis. It may also have potential in treating mood disorders such
as depression and anxiety.
Blood Analysis
Although not required for PT-141, a blood analysis provides a roadmap how to proceed.
01
Review & Consult
Review bloodwork and work together to discuss treatment plan.
02
Protocol
Individualized protocol designed for each patient.
03
Connect with us
Request a Consultation
Obtain a no-cost consultation to ascertain if you qualify for our peptides and hormones programs, and communicate with our patient advocates who are available to address any inquiries you might have.
PT-141
PT-141 works by activating the melanocortin receptors in the brain, which play a role in regulating sexual behavior and arousal. It has been found to increase sexual desire and arousal in both men and women.
In clinical trials, PT-141 has been shown to be effective in treating female sexual arousal disorder and male erectile dysfunction. It has been found to increase sexual desire and improve sexual function in both men and women.
PT-141 is typically administered via injection, either subcutaneously or intranasally. It is important to note that PT-141 is not a cure for sexual dysfunction and may not work for everyone. It is also not recommended for use in individuals with a history of cardiovascular disease or uncontrolled high blood pressure.
PT-141 has also been found to have potential therapeutic applications beyond sexual dysfunction. It has been shown to have neuroprotective properties and may have potential in treating conditions such as Parkinson's disease and multiple sclerosis. It may also have potential in treating mood disorders such as depression and anxiety.
Blood Analysis
Review & Consult
Protocol